These data extend the findings from that prior report and show that GPER protein is expressed in a high percentage of colon, pancreatic, melanoma, and lung cancer cases, consistent with reports showing efficacy in these preclinical models (3, 4, 17–19). This evidence concerns the gene GPER1 and lung cancer.